The historical rank and industry rank for Vycor Medical's Gross Margin % or its related term are showing as below:
VYCO'
s Gross Margin % Range Over the Past 10 Years
Min: 83.61 Med: 88.46 Max: 90.31
Current: 89.42
During the past 13 years, the highestGross Margin % of Vycor Medical was 90.31%. The lowest was 83.61%. And the median was 88.46%.
VYCO's Gross Margin % is ranked better than 95.24% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 52.83
vs VYCO: 89.42
Vycor Medical had a gross margin of 89.02% for the quarter that ended in Mar. 2024 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Vycor Medical was 0.10% per year.
Vycor Medical Gross Margin % Historical Data
The historical data trend for Vycor Medical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vycor Medical's Gross Margin %
For the Medical Devices subindustry, Vycor Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vycor Medical's Gross Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Vycor Medical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Vycor Medical (OTCPK:VYCO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Vycor Medical had a gross margin of 89.02% for the quarter that ended in Mar. 2024 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Vycor Medical Gross Margin % Related Terms
Thank you for viewing the detailed overview of Vycor Medical's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Vycor Medical (Vycor Medical) Business Description
Vycor Medical Inc is engaged in designing, developing and marketing medical devices for use in neurosurgery in the United States. It has developed ViewSite Brain Access System, which helps to reduce brain tissue trauma that arises from excessive pressure at the edges of the blade. It also provides non-invasive rehabilitation therapies for patients having disorders resulting from neurological brain damage caused by a stroke. The company operates through two segments: Vycor Medical, which focuses on devices for neurosurgery; and NovaVision, which focuses on neurostimulation therapies and diagnostic devices for the treatment and screening of visual field loss. The majority of the revenue comes from the Vycor Medical segment in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VYCO has been successfully added to your 